These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24716719)

  • 1. Flunisolide for the treatment of asthma.
    Melani AS
    Expert Rev Clin Pharmacol; 2014 May; 7(3):251-8. PubMed ID: 24716719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
    Corren J; Tashkin DP
    Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
    Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flunisolide HFA.
    Waugh J; Goa KL
    Am J Respir Med; 2002; 1(5):369-72; discussion 373. PubMed ID: 14720039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One-year trial on safety and normal linear growth with flunisolide HFA in children with asthma.
    Gillman SA; Anolik R; Schenkel E; Newman K
    Clin Pediatr (Phila); 2002 Jun; 41(5):333-40. PubMed ID: 12086199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flunisolide hydrofluoroalkane with integrated spacer for treating asthma: an updated review.
    Berger WE; Tashkin DP
    Allergy Asthma Proc; 2015; 36(2):105-15. PubMed ID: 25635610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide.
    Nolting A; Sista S; Abramowitz W
    J Pharm Sci; 2002 Feb; 91(2):424-32. PubMed ID: 11835202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flunisolide HFA for the treatment of asthma: an old friend reformulated.
    Shafazand S; Colice G
    Expert Opin Pharmacother; 2004 May; 5(5):1163-73. PubMed ID: 15155115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
    Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
    J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flunisolide HFA vs flunisolide CFC: pharmacokinetic comparison in healthy volunteers.
    Nolting A; Sista S; Abramowitz W
    Biopharm Drug Dispos; 2001 Dec; 22(9):373-82. PubMed ID: 11870676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: a randomized, double-blind, placebo-controlled trial.
    Bensch GW; Greos LS; Gawchik S; Kpamegan E; Newman KB
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):323-9. PubMed ID: 21962092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience.
    Kantar A; Mroueh S; Fiocchi A
    Allergy Asthma Proc; 2007; 28(6):671-87. PubMed ID: 17883883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple-dose proportionality study of flunisolide hydrofluoroalkane.
    Nolting A; Abramowitz W
    Allergy Asthma Proc; 2002; 23(5):311-8. PubMed ID: 12476540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small airway asthma therapy, challenges, and the future.
    Casale TB
    Postgrad Med; 2003 Feb; 113(2 Suppl):15-20. PubMed ID: 19667625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placebo-controlled, comparative study of the efficacy and safety of triamcinolone acetonide inhalation aerosol with the non-CFC propellant HFA-134a in patients with asthma. Azmacort HFA Clinical Study Group.
    Jacobson K; Chervinsky P; Noonan M; Kane RE; Banerji D; Uryniak T
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):327-33. PubMed ID: 10541425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with inhaled flunisolide.
    Edmonds ML; Rowe BH
    Chest; 2004 May; 125(5):1961-2; author reply 1962-3. PubMed ID: 15136418
    [No Abstract]   [Full Text] [Related]  

  • 17. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patients.
    Casale TB; Nelson HS; Stricker WE; Raff H; Newman KB
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):379-85. PubMed ID: 11730179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide.
    Bergeron C; Hauber HP; Gotfried M; Newman K; Dhanda R; Servi RJ; Ludwig MS; Hamid Q
    J Allergy Clin Immunol; 2005 Nov; 116(5):983-9. PubMed ID: 16275364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S; Warner J; Wahn U; Staab D; Le Bourgeois M; Van Essen-Zandvliet E; Arora S; Szefler SJ;
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids.
    Guilbert TW; Colice G; Grigg J; van Aalderen W; Martin RJ; Israel E; Postma DS; Roche N; Phipatanakul W; Hillyer EV; Evans JM; Dolovich MB; Price DB;
    J Allergy Clin Immunol Pract; 2017; 5(4):1040-1049.e4. PubMed ID: 28110057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.